SecBot SecBot
PRESS-RELEASE ·Filed Mar 18, 2026

SPRO

Spero Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed8mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Traders should prepare for a potentially muted reaction post-release due to lack of a conference call; monitor the earnings press release closely for any surprises in financials or pipeline updates.

DirectionNeutral
Confidencemedium
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$2.47
T+0 close · Mar 18, 2026 · via day close
Latest settled
+17.81%
T+60 · $2.91
Vs SPY
+3.47%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 19 $2.47entry
  2. T+1 · 8mo ago −4.05%α −2.31% · $2.37
  3. T+5 · 8mo ago −4.05%α −1.84% · $2.37
  4. T+20 · 7mo ago +11.34%α +3.71% · $2.75
  5. T+60 · 5mo ago +17.81%α +3.47% · $2.91
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Spero Therapeutics announced it will release its Q4 and full-year 2025 financial results on March 26, 2026, after market close. The company will not host a conference call, limiting immediate investor engagement and real-time clarification of results.

Key Facts

  • Spero Therapeutics will report Q4 and full-year 2025 financial results on March 26, 2026, after market close.
  • No conference call is planned, which may limit investor interaction and near-term market reaction.
  • Company remains focused on clinical-stage development for rare and high unmet need diseases.

Financial Impact

Results pending, no financial figures provided in this release

revenueepscashFlow

Risk Factors

  • Lack of management commentary via conference call increases risk of misinterpretation or delayed reaction to results.
  • As a clinical-stage biopharma with no commercial revenue, financial results will likely reflect continued R&D spend and cash burn.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3258588

Track record

17 reports on SPRO

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.59% at T+20 after the Mar 26, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $0.9999 Now $0.9460 −5.39% settles Nov 20
  2. Nov 10, 20266d ago 3 Neutral 2/10 Entry $1.02 Now $0.9460 −7.25% settles Nov 18
  3. Nov 10, 20266d ago 8-K Neutral 2/10 Entry $1.02 Now $0.9460 −7.25% settles Nov 18
  4. Oct 27, 202620d ago 8-K Neutral 2/10 Entry $1.17 to $1.07 Now $0.9460 −19.15% ▼ −8.55% −7.83% vs SPY
  5. Sep 11, 20269w ago EFFECT Bearish 7/10 Entry $1.13 to $1.13 Now $0.9460 +16.28% · 0.00% −0.34% vs SPY
  6. Aug 28, 202611w ago 8-K Bearish 7/10 Entry $1.22 to $1.19 Now $0.9460 +22.46% ▲ +2.46% +2.32% vs SPY
  7. Aug 28, 202611w ago S-3 Bearish 7/10 Entry $1.22 to $1.19 Now $0.9460 +22.46% ▲ +2.46% +2.32% vs SPY
  8. Aug 12, 202613w ago Press Release Neutral 4/10 Entry $1.24 to $1.22 Now $0.9460 −23.71% ▼ −1.61% +0.35% vs SPY
  9. Jul 14, 202617w ago 8-K Bullish 8/10 Entry $1.70 to $1.44 Now $0.9460 −44.35% ▼ −15.29% −14.00% vs SPY
  10. Jul 14, 202617w ago Press Release Bullish 7/10 Entry $1.70 to $1.44 Now $0.9460 −44.35% ▼ −15.29% −14.00% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (10h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 18, 2026